Cargando…

A252 LONG-TERM OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: KINGSTON HEALTH SCIENCES CENTER LOCAL EXPERIENCE

BACKGROUND: IBD-PSC remains a poorly understood entity due to it’s low incidence and the heterogeneity found within this patient population. Patients with IBD-PSC have 0.3-2.8% lifetime risk of developing hepatocellular carcinoma, up to a 20% lifetime risk of developing Cholangiocarcinoma and a 20-3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greenblatt, M, Mulder, D, Flemming, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991255/ http://dx.doi.org/10.1093/jcag/gwac036.252

Ejemplares similares

IKKα modulates primary sclerosing cholangitis and intrahepatic cholangiocarcinoma
por: Jiang, Qun, et al.
Publicado: (2014)

Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children
por: Yoon, Jisun, et al.
Publicado: (2015)

Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review
por: Da Cunha, Teresa, et al.
Publicado: (2022)

Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
por: Kim, You Sun, et al.
Publicado: (2023)

Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Fousekis, Fotios S., et al.
Publicado: (2019)

Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence
por: Mertz, Andrew, et al.
Publicado: (2019)

The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Lynch, Kate D., et al.
Publicado: (2019)

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
por: Lynch, Kate D., et al.
Publicado: (2020)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Cockroach sensitivity in allergic rhinitis patients; is it significant? To see prevalence of cockroach sensitivity in allergic rhinitis patients in Kingston area
por: Batool, Tahira, et al.
Publicado: (2010)

Prevalence of allergic sensitization to Russian thistle in Kingston and the South-eastern Ontario catchment area; a retrospective chart review
por: Lakhani, Nina, et al.
Publicado: (2010)

Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis
por: Bjarnason, Ingvar, et al.
Publicado: (2015)

Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease
por: Kim, Kwang Woo, et al.
Publicado: (2023)

Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
por: Singh, Arshdeep, et al.
Publicado: (2023)

Long-Term Follow-Up into Adulthood of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis
por: Hercun, Julian, et al.
Publicado: (2022)

The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival
por: Chahal, Daljeet, et al.
Publicado: (2020)

Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
por: Park, Yong Eun
Publicado: (2022)

Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
por: de Krijger, Manon, et al.
Publicado: (2022)

Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease
por: Wang, Ming-Hsi, et al.
Publicado: (2023)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features
por: Palmela, Carolina, et al.
Publicado: (2018)

Inflammatory Bowel Disease and Primary Sclerosing Cholangitis in a Pediatric Patient With Neurofibromatosis Type 1
por: Lehan, Emily, et al.
Publicado: (2021)

Tissue-dependent transcriptional and bacterial associations in primary sclerosing cholangitis-associated inflammatory bowel disease
por: Ilott, Nicholas E., et al.
Publicado: (2022)

Omental torsion: diagnostic challenge in patients with sclerosing cholangitis and inflammatory bowel disease – case report
por: Malik, Neha, et al.
Publicado: (2023)

Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease
por: Gwela, Agnes, et al.
Publicado: (2017)

Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis–Inflammatory Bowel Disease
por: Chung, Brian K., et al.
Publicado: (2018)

Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease
por: Weng, Meng-Tzu, et al.
Publicado: (2022)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

Primary sclerosing cholangitis and pregnancy
por: Kammeijer, Casper Q., et al.
Publicado: (2011)

Sclerosing Cholangitis in Behçet's Disease
por: Ben Slama Trabelsi, Aida, et al.
Publicado: (2013)

An Overview on Primary Sclerosing Cholangitis
por: Vlăduţ, Cătălina, et al.
Publicado: (2020)

P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine
por: Liu, J, et al.
Publicado: (2009)

A210 HEPATOLITHIASIS IS A FREQUENT AND PROGNOSTIC FINDING IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
por: Jubran, B, et al.
Publicado: (2022)

Frequency and risk factors of primary sclerosing cholangitis among patients with inflammatory bowel disease in North-East of Iran
por: Khosravi Khorashad, Ahmad, et al.
Publicado: (2015)

Diagnostic yield of endomicroscopy for dysplasia in primary sclerosing cholangitis associated inflammatory bowel disease: a feasibility study
por: Dlugosz, Aldona, et al.
Publicado: (2016)

Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis
por: Mouchli, Mohamad A, et al.
Publicado: (2018)

Tumor Necrosis Factor Alpha Inhibition for Inflammatory Bowel Disease after Liver Transplant for Primary Sclerosing Cholangitis
por: Parekh, Ravish, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ch55pba79jfm74sgqt9svkdtit